A pill for infertility: Oxolife’s non-hormonal oral drug raises embryo implantation rate, pregnancy rates and live birth rate in women undergoing IVF and ICSI, data being presented at ESHRE shows

Oxolife’s OXO-001 is a safe, first-in-class drug designed to improve the odds of an embryo embedding by making the endometrium more conducive to implantation Ongoing pregnancy rate was 10.6 percentage points higher in women who received OXO-001 than in those who received a placebo (46.3%…